CoChat

Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials

Open access
Clippinger, Amy J., Ahluwalia, Arti, Allen, David, Bonner, James C., Casey, Warren, Castranova, Vincent, David, Raymond M., Halappanavar, Sabina, Hotchkiss, Jon A., Jarabek, Annie M., Maier, Monika, Polk, William, Rothen-Rutishauser, Barbara, Sayes, Christie M., Sayre, Phil, Sharma, Monita, Stone, Vicki · 2016 · Archives of Toxicology
Cited by 63

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The increasing use of multi-walled carbon nanotubes (MWCNTs) in consumer products and their potential to induce adverse lung effects following inhalation has lead to much interest in better understanding the hazard associated with these nanomaterials (NMs). While the current regulatory requirement for substances of concern, such as MWCNTs, in many jurisdictions is a 90-day rodent inhalation test, the monetary, ethical, and scientific concerns associated with this test led an international expert group to convene in Washington, DC, USA, to discuss alternative approaches to evaluate the inhalation toxicity of MWCNTs. Pulmonary fibrosis was identified as a key adverse outcome linked to MWCNT exposure, and recommendations were made on the design of an in vitro assay that is predictive of the fibrotic potential of MWCNTs. While fibrosis takes weeks or months to develop in vivo, an in vitro test system may more rapidly predict fibrogenic potential by monitoring pro-fibrotic mediators (e.g., cytokines and growth factors). Therefore, the workshop discussions focused on the necessary specifications related to the development and evaluation of such an in vitro system. Recommendations were made for designing a system using lung-relevant cells co-cultured at the air-liquid interface to assess the pro-fibrogenic potential of aerosolized MWCNTs, while considering human-relevant dosimetry and NM life cycle transformations. The workshop discussions provided the fundamental design components of an air-liquid interface in vitro test system that will be subsequently expanded to the development of an alternative testing strategy to predict pulmonary toxicity and to generate data that will enable effective risk assessment of NMs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-016-1717-8

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 63

Metadata

Authors
Clippinger, A. J., Ahluwalia, A., Allen, D., Bonner, J. C., Casey, W., Castranova, V., David, R. M., Halappanavar, S., Hotchkiss, J. A., Jarabek, A. M., Maier, M., Polk, W., Rothen-Rutishauser, B., Sayes, C. M., Sayre, P., Sharma, M., & Stone, V.
Venue
Archives of Toxicology
Published
2016-04-27
Volume
90
Issue
7
Pages
1769-1783
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W2344558615
Cited by
63
References
10
FWCI
6.89
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials. https://app.cochat.ai/papers/10.1007/s00204-016-1717-8
The paper
Clippinger, A. J., Ahluwalia, A., Allen, D., Bonner, J. C., Casey, W., Castranova, V., David, R. M., Halappanavar, S., Hotchkiss, J. A., Jarabek, A. M., Maier, M., Polk, W., Rothen-Rutishauser, B., Sayes, C. M., Sayre, P., Sharma, M., & Stone, V. (2016). Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials. Archives of Toxicology. https://doi.org/10.1007/s00204-016-1717-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.